News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

|Articles|March 18, 2020

Offer for Trial Planning Software for COVID-19 Sponsors

Strategikon Pharma is now offering Clinical Maestro, its clinical trial planning, budgeting and sourcing technology software pro bono to any company sponsoring COVID-19 clinical trials, in order to help researchers during this public health emergency.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Stock.adobe.com

Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher

ByNicholas Jacobus

November 28th 2025

© PIC4U - © PIC4U - stock.adobe.com

FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers

ByAndy Studna, Senior Editor

November 26th 2025

The CRA Role’s Co-evolution With Clinical Trial Technology

ByHelen Yeardley

November 26th 2025

ACT Brief: AI in Clinical Research, FDA Gene Therapy Approval, and High-Performing Hospital Partnerships

ByAndy Studna, Senior Editor

November 26th 2025

© Rochu_2008 - © Rochu_2008 - stock.adobe.com

FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA

ByAndy Studna, Senior Editor

November 25th 2025

Trending on Applied Clinical Trials Online

Is Artificial Intelligence Coming for Clinical Research?

Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher

FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers

The CRA Role’s Co-evolution With Clinical Trial Technology

FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA

© 2025 MJH Life Sciences^®

All rights reserved.